These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32931896)

  • 1. Kidney-targeted therapies: A quantitative perspective.
    van Asbeck AH; Dieker J; Boswinkel M; van der Vlag J; Brock R
    J Control Release; 2020 Dec; 328():762-775. PubMed ID: 32931896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting strategies for drug delivery to the kidney: From renal glomeruli to tubules.
    Liu CP; Hu Y; Lin JC; Fu HL; Lim LY; Yuan ZX
    Med Res Rev; 2019 Mar; 39(2):561-578. PubMed ID: 30136283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted nanotherapy for kidney diseases: a comprehensive review.
    Sabiu G; Kasinath V; Jung S; Li X; Tsokos GC; Abdi R
    Nephrol Dial Transplant; 2023 May; 38(6):1385-1396. PubMed ID: 35945647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide and Low Molecular Weight Proteins Based Kidney Targeted Drug Delivery Systems.
    Xu P; Zhang H; Dang R; Jiang P
    Protein Pept Lett; 2018; 25(6):522-527. PubMed ID: 29848259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant-Derived Biomolecules and Drug Delivery Systems in the Treatment of Liver and Kidney Diseases.
    Hermenean A; Smeu C; Gharbia S; Krizbai IA; Ardelean A
    Curr Pharm Des; 2016; 22(35):5415-5441. PubMed ID: 27464717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting therapeutics to the glomerulus with nanoparticles.
    Zuckerman JE; Davis ME
    Adv Chronic Kidney Dis; 2013 Nov; 20(6):500-7. PubMed ID: 24206602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential of RNA-based therapy for kidney diseases.
    Bondue T; van den Heuvel L; Levtchenko E; Brock R
    Pediatr Nephrol; 2023 Feb; 38(2):327-344. PubMed ID: 35507149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasmall polymeric nanocarriers for drug delivery to podocytes in kidney glomerulus.
    Bruni R; Possenti P; Bordignon C; Li M; Ordanini S; Messa P; Rastaldi MP; Cellesi F
    J Control Release; 2017 Jun; 255():94-107. PubMed ID: 28395969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific drug delivery to the kidney.
    Haas M; Moolenaar F; Meijer DK; de Zeeuw D
    Cardiovasc Drugs Ther; 2002 Dec; 16(6):489-96. PubMed ID: 12766381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. l-Serine-modified polyamidoamine dendrimer as a highly potent renal targeting drug carrier.
    Matsuura S; Katsumi H; Suzuki H; Hirai N; Hayashi H; Koshino K; Higuchi T; Yagi Y; Kimura H; Sakane T; Yamamoto A
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10511-10516. PubMed ID: 30249662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular disease augments kidney accumulation of synthetic anionic polymers.
    Liu GW; Prossnitz AN; Eng DG; Cheng Y; Subrahmanyam N; Pippin JW; Lamm RJ; Ngambenjawong C; Ghandehari H; Shankland SJ; Pun SH
    Biomaterials; 2018 Sep; 178():317-325. PubMed ID: 29891232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-mediated drug delivery.
    Arslan FB; Ozturk Atar K; Calis S
    Int J Pharm; 2021 Mar; 596():120268. PubMed ID: 33486037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Drug Delivery Technologies and Targets for Renal Disease.
    Chade AR; Bidwell GL
    Hypertension; 2022 Sep; 79(9):1937-1948. PubMed ID: 35652363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the glucocorticoid receptor in glomerular disease.
    Goodwin JE
    Am J Physiol Renal Physiol; 2019 Jul; 317(1):F133-F136. PubMed ID: 31166704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles in drug delivery: mechanism of action, formulation and clinical application towards reduction in drug-associated nephrotoxicity.
    Cooper DL; Conder CM; Harirforoosh S
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1661-80. PubMed ID: 25054316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney targeted delivery of asiatic acid using a FITC labeled renal tubular-targeting peptide modified PLGA-PEG system.
    He J; Chen H; Zhou W; Chen M; Yao Y; Zhang Z; Tan N
    Int J Pharm; 2020 Jun; 584():119455. PubMed ID: 32464235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal targeting of kinase inhibitors.
    Dolman ME; Fretz MM; Segers GJ; Lacombe M; Prakash J; Storm G; Hennink WE; Kok RJ
    Int J Pharm; 2008 Dec; 364(2):249-57. PubMed ID: 18550305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.